|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910787593503321 |
|
|
Titolo |
Monoclonal antibodies in oncology / / editor, Fatih M. Uckun |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
London, England : , : Future Medicine Ltd., , [2013] |
|
©2013 |
|
|
|
|
|
|
|
|
|
ISBN |
|
1-78084-327-5 |
1-78084-222-8 |
|
|
|
|
|
|
|
|
Edizione |
[1st ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (85 p.) |
|
|
|
|
|
|
Collana |
|
Future Medecine, , 2047-332X |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Monoclonal antibodies - Therapeutic use |
Antibody-toxin conjugates - Therapeutic use |
Cancer - Immunotherapy |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references at the end of each chapters and index. |
|
|
|
|
|
|
|
|
Nota di contenuto |
|
Title page; Copyright page; Contents; Foreword. Monoclonal antibodies in contemporary cancer therapy; 1. mAbs targeting CD20 and other lymphocyte CD markers in lymphoma treatment; 2. mAbs targeting CTLA-4 and clinical outcomes; 3. mAbs targeting VEGF/VEGFR and clinical outcomes in cancer treatment; 4. mAbs targeting RANKL in bone metastasis treatment; 5. Novel monoclonal antibody-based therapies for leukemia; Index |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
Monoclonal antibodies (mAbs) have been developed to improve the treatment outcome of cancer patients undergoing therapy according to multimodality regimens without a significant increase of treatment-associated toxicity. This five-chapter book provides examples where mAbs that have become part of the standard of care in cancer patients and cancer types that have responded to mAbs |
|
|
|
|
|
|
|